Skip to content

Differential analysis of gut microbiota and its metabolites in diabetic kidney disease patients with different urinary albumin stages

Differential analysis of gut microbiota and its metabolites in diabetic kidney disease patients with different urinary albumin stages

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072113
Enrollment
Unknown
Registered
2023-06-02
Start date
2023-06-30
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus, diabetic kidney disease, end-stage renal disease

Interventions

? Group A1: UACR300 mg/g
:none
? Normal group (matched by gender and age):none

Sponsors

The Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the 1999 World Health Organization (WHO) diagnostic criteria for diabetes: typical diabetic symptoms plus random plasma glucose =11.1mmol/L or fasting plasma glucose =7.0mmol/L or OGTT 2h plasma glucose =11.1mmol/L; 2. In line with the 2014 American Diabetes Association (ADA) and the American National Kidney Foundation (NKF) diagnostic criteria for diabetic kidney disease (DKD): when the urinary albumin/creatinine ratio (UACR) is =30 mg/g, except for other Increased urinary albumin due to disease; 3. The age of the patient is 18-75 years old, and the gender is not limited; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Other secondary nephritis not caused by diabetes; 2. Antibiotics have been used within 1 month before enrollment; 3. Pregnant and lactating women; 4. The mentally ill or incapacitated; 5. People who are addicted to alcohol or drugs; 6. Long-term adherence to a special dietary regimen; 7. Colorectal or other diseases known to affect the gut microbiota; 8. Participating in other intervention projects affecting gut microbiota in or in the past 3 months.

Design outcomes

Primary

MeasureTime frame
gut microbiota;fecal Metabolomics;serum metabolomics;urinary albumin / creatinine ratio;estimated glomerular filtration rate;

Secondary

MeasureTime frame
inflammatory factor;

Countries

China

Contacts

Public ContactWanghan

The Affiliated Hospital of Changchun University of Chinese Medicine

wanghan2020tcm@163.com+86 188 4450 5735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026